Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
142
Views
7
CrossRef citations to date
0
Altmetric
Review

The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting

Massimiliano Salati1 Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy;2 PhD Program Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, ItalyCorrespondence[email protected]
,
Francesco Caputo1 Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy
,
Cinzia Baldessari1 Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy
,
Pietro Carotenuto3 Department of Genomics, Telethon Institute of Genetics and Medicine (TIGEM), Naples, ItalyORCID Iconhttps://orcid.org/0000-0002-6622-183X
ORCID Icon,
Marco Messina4 Department of Oncology, Fondazione Istituto G. Giglio, Cefalu, Italy
,
Stefania Caramaschi5 Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia – AOU Policlinico of Modena, Modena, Italy
,
Massimo Dominici1 Department of Oncology and Hematology, University Hospital of Modena, Modena, ItalyORCID Iconhttps://orcid.org/0000-0002-4007-1503
ORCID Icon &
Luca Reggiani Bonetti5 Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia – AOU Policlinico of Modena, Modena, Italy
 show all
Pages 7747-7757 | Published online: 09 Oct 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Yuhang Li, Jianfeng Yu, Yujing Zhang, Chuang Peng, Yinghui Song & Sulai Liu. (2024) Advances in targeted therapy of cholangiocarcinoma. Annals of Medicine 56:1.
Read now
Lixia Yi, Xiaoyan Zhu, Jing Xie & Zhiqiang Meng. (2023) Long-lasting complete response to SHR-1701 plus famitinib in refractory advanced gallbladder cancer: A case report. Human Vaccines & Immunotherapeutics 19:3.
Read now
Nikolaos Skouteris, Georgios Papageorgiou, Rodanthi Fioretzaki, Dimitrios Schizas, Stylianos Kykalos, Maria Tolia & Nikolaos Charalampakis. (2023) Immune Checkpoint Inhibitors and Combinations with Other Agents in Cholangiocarcinoma. Immunotherapy 15:7, pages 487-502.
Read now

Articles from other publishers (4)

Ruchi Sharma, Chandana Majee, Rupa Mazumder, Avijit Mazumder, Pankaj Kumar Tyagi & M. V. N. L. Chaitanya. (2024) Insight Into the Role of Alkaloids in the Different Signalling Pathways of Cholangiocarcinoma. Journal of Natural Remedies, pages 43-58.
Crossref
Cindy E. Ament, Sara Steinmann, Katja Evert, Giovanni M. Pes, Silvia Ribback, Isabella Gigante, Elena Pizzuto, Jesus M. Banales, Pedro M. Rodrigues, Paula Olaizola, Haichuan Wang, Gianluigi Giannelli, Xin Chen, Matthias Evert & Diego F. Calvisi. (2023) Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma. Hepatology 78:6, pages 1742-1754.
Crossref
Pietro Carotenuto, Sergio A. Gradilone & Brunella Franco. (2023) Cilia and Cancer: From Molecular Genetics to Therapeutic Strategies. Genes 14:7, pages 1428.
Crossref
Anna Barbato, Fabiola Piscopo, Massimiliano Salati, Luca Reggiani-Bonetti, Brunella Franco & Pietro Carotenuto. (2022) Micro-RNA in Cholangiocarcinoma: Implications for Diagnosis, Prognosis, and Therapy. Journal of Molecular Pathology 3:2, pages 88-103.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.